No-Reflow Phenomenon: Clinical Trials

4 trials for No-Reflow Phenomenon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow No-Reflow Phenomenon: new trials by email Literature Review of No-Reflow Phenomenon trials Research Report on No-Reflow Phenomenon

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adrenaline for the Treatment of No-Reflow in Normotensive Patients
Adrenaline, Adenosine - Acute Coronary Syndrome, No-Reflow Phenomenon
Phase 4CompletedNational Institute of Cardiovascular Diseases, Pakistan2012021-01-012021-05-21
Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Prourokinase, Tirofiban, normal saline - Myocardial Infarction, Percutaneous Coronary Intervention
Phase 4CompletedFudan University3622015-11-012018-08-07
Intracoronary Tirofiban on No-Reflow Phenomena
Tirofiban, Placebo - No-Reflow Phenomenon
Phase 4CompletedTC Erciyes University1622011-01-012014-02-04
Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction
Diltiazem, Verapamil, Nitroglycerin - Acute Myocardial Infarction, Percutaneous Coronary Intervention
Phase 4CompletedFudan University1022006-12-012012-09-24

Narrower conditions

Acute Coronary Syndrome (1)  ·  Myocardial Infarction (1)

Broader conditions

Ischemia (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Vascular Diseases (2)  ·  Infarction (1)  ·  Necrosis (1)

Interventions

Tirofiban (2)  ·  Adenosine (1)  ·  Diltiazem (1)  ·  Epinephrine (1)  ·  Injections (1)  ·  Nitroglycerin (1)  ·  Saline Solution (1)  ·  Verapamil (1)  ·  saruplase (1)

Sponsors

Fudan University (2)  ·  National Institute of Cardiovascular Diseases, Pakistan (1)  ·  TC Erciyes University (1)

Countries

China (2)  ·  Pakistan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Junbo Ge, M.D. (2)

Results publications

PMID 22980307, PMID 35000456